Use access key #2 to skip to page content.
$1.23 0.01 (0.81%)
7/23/2008 3:59 PM

AVI BioPharma, Inc. (AVII)

CAPS Rating:
**

A biopharmaceutical company developing therapeutic products principally based on third-generation NEUGENE antisense technology.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other members to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

Ticker Not Ratable

AVII doesn't currently meet the $100M market cap / $1.50 stock price minimum. (Learn More)

What the Community Thinks

Total Members

84 Outperforms
11 Underperforms
 

All-Stars

12 Outperforms
6 Underperforms
 

Wall Street

2 Outperforms
1 Underperforms
 

Members bullish on AVII are also bullish on:

Members bearish on AVII are also bearish on:

Ticker Tags

Drug Manufacturers - Other (105), Biotechnology (294), Micro Cap (4824)
Suggest a tag

AVI BioPharma, Inc. At A Glance

Current Price: $1.23
Last Trade Time: 7/23/2008 3:59 PM
Open: $0.00
Previous Close: $1.23
Daily Range: $1.20 - $1.24
52-Week Range: $1.01 - $3.14
Volume: 94,633
Market Cap: $87.28M
P/E Ratio: 0.00
Compare Our Special Broker Offers!

Stock Trends

AVII VS S&P 500 (SPY)

AVII 12 month chart vs. S&P

News & Discussion Boards

Other News Headlines for AVII

More Headlines...

Top Bull Pitch

Recs

1

AVI BioPharma, Inc. (AVII)

Avatar zzlangerhans (91.05) Submitted: 11/24/07 6:01 AM

I'm not confident enough in this pick to buy it in real life, but I'm trying to increase my CAPS volume and I'm running out of small cap biotechs. Basically, it seems that AVI has too much going on for a 128M market cap. The flipside is that it could be another Introgen, always talking loud but sayi...More

Replies: 0 | Reply | Permalink

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

CAPS Members

picks per page. CHANGE

Results 1 - 5 of 20 :   1 2 3 4 Next »

Recs

1

 (AVII)

Avatar zzlangerhans (91.05) Submitted: 11/24/07 6:01 AM : Outperform Start Price: $2.50 AVII Score: -39.57

I'm not confident enough in this pick to buy it in real life, but I'm trying to increase my CAPS volume and I'm running out of small cap biotechs. Basically, it seems that AVI has too much going on for a 128M market cap. The flipside is that it could be another Introgen, always talking loud but saying nothing. I'm not happy with the progress made in the anti-restenosis pipeline this year. Then again, the antiviral stuff for the DOD was encouraging. The low cash reserve indicates an upcoming dilutional financing, but that doesn't seem to damage stock prices much at these low market caps. I think the stock has a good chance to shoot up after the dilutional financing, especially with any good news coming from one of their multiple trials.

Report this Post Replies: 0 | Reply | Permalink

Recs

1

 (AVII)

Avatar StrategyGuru (< 20) Submitted: 10/22/07 9:14 AM : Outperform Start Price: $2.82 AVII Score: -42.51

This company recently changed it's management team and has made progress in obtaining govt. work. As with many companies, growing the federal allotment of funds provides stability & cashflow to accelerate growth. Look for federal funds to increase as well as new ventures.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (AVII)

Avatar audiowhore (54.69) Submitted: 5/08/07 6:21 AM : Outperform Start Price: $3.04 AVII Score: -44.68

just picked up a few shares monday for 3.05 a share on the basis the D.O.D. gave them a VERY SMALL chunk of change, I think just barely above $7mil to develope some homeland security vacines. The 52 wk high is more than double the current price. blah blah blah, it was an impulse buy.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (AVII)

Avatar nero2000 (65.92) Submitted: 5/07/07 8:49 AM : Outperform Start Price: $3.26 AVII Score: -47.24

AVII is on the cutting edge of a huge wave of biopharma innovation that promises to transform modern medicine and healthcare.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (AVII)

Avatar gzulauf1 (42.91) Submitted: 3/09/07 5:45 PM : Outperform Start Price: $2.45 AVII Score: -41.10

Risky, very promising technology, questionable management.

Report this Post Replies: 0 | Reply | Permalink

Results 1 - 5 of 20 :   1 2 3 4 Next »

Wall Street

Results 1 - 3 of 3  

picks per page. CHANGE

Top
Pick
Member NameMember RatingStart
Date
CallTime FrameStart
Price
Stock
Gain
S&P
Gain
ScorePitch
TrackRodmanRen < 20 08/13/07 08/13/07 Outperform NS $2.89-57.44%-12.48%-44.95
TrackMaximGroup < 20 03/30/07 03/30/07 Outperform NS $2.53-51.38%-9.86%-41.52
TrackJimCramer 81.15 03/15/06 03/15/06 Underperform 3W $6.95-82.30%-1.91%+80.39

Results 1 - 3 of 3  

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners